Children's Cancer Center – Trademark Portfolio
Entity Type: 03
Children's Cancer Center holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 41 (Education & Entertainment) — 1 filings in this category. The portfolio also extends into Class 36 (Insurance & Financial) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include RIDE. RESTORE. REFRESH.. The owner is based in Tampa, FL.
4901 W Cypress St.
Tampa, FL 33607
Showing of trademarks Trademarks
Trademark Classifications
Children's Cancer Center's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Education; providing of training; entertainment; sporting and cultural activities
Insurance; financial affairs; monetary affairs; real estate affairs
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does Children's Cancer Center have?
Children's Cancer Center has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 abandoned.
What trademark classes does Children's Cancer Center file in?
Children's Cancer Center files trademarks across 3 Nice Classification classes. The most active classes are Class 41 (Education & Entertainment), Class 36 (Insurance & Financial), Class 44 (Medical Services). Class 41 covers education; providing of training; entertainment; sporting and cultural activities.
What are Children's Cancer Center's most well-known trademarks?
Children's Cancer Center's registered trademark portfolio includes well-known marks such as RIDE. RESTORE. REFRESH.. These are among 1 currently registered trademark in the portfolio.
What is Children's Cancer Center's trademark registration success rate?
Children's Cancer Center has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.